
Our
Impact Report
scroll
Working with our members to improve CF patients health outcomes across the region
2021/22
![]() | ![]() | ![]() | ![]() |
---|---|---|---|
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() |

Our passion
Dear MECFA Members and sponsors,
We are once again proud to present our annual report covering 2021 and 22. Though slowed during the initial outbreak of the COVID 19 pandemic, these past two years have seen us carryout our diagnostic program, provide training for clinicians and families and actively lobby for patients access to essential drugs. In addition to our successful education, diagnostic and advocay programs, 2022 saw the launch of the MECFA Access Program aimed at opening access to affordable essential drugs for patients in our region. MECFA added a new virtual education platform to our website that inludeds technical training videos, lectures and QI workshops. With every program MECFA continues to focus on improving patient health outcome to increase their life expectancy. We are grateful to all of you who continue to support the work we do.
Yours truly,
CEO and President
Middle East CF Association, MECFA

scroll

We Invest Smartly
MECFA once again spent over 89% of our income on programs directly improving patients health outcomes. Revdiew our 990 finacial reports to learn exactly where your dollars go.